The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Aldeyra Therapeutics Inc shares valued at $13,250 were purchased by Alfieri Michael on Aug 13 ’25. At $5.30 per share, Alfieri Michael acquired 2,500 shares. The insider’s holdings grew to 2,500 shares worth approximately $13475.0 following the completion of this transaction.
Also, Machatha Stephen sold 22,073 shares, netting a total of over 113,713 in proceeds. Following the sale of shares at $5.15 each, the insider now holds 221,799 shares.
Before that, Machatha Stephen had added 22,074 shares to its account. In a trade valued at $116,109, the Officer bought Aldeyra Therapeutics Inc shares for $5.26 each.
As published in a research note from Oppenheimer on April 03, 2024, Aldeyra Therapeutics Inc [ALDX] has been rated up from a Perform to an Outperform and the price target has been revised to $10. Earlier on February 08, 2021, H.C. Wainwright initiated its rating. Their recommendation was “a Buy” for ALDX stock.
Analyzing ALDX Stock Performance
On last trading session, Aldeyra Therapeutics Inc [NASDAQ: ALDX] plunged -4.77% to $5.39. The stock’s lowest price that day was $5.39, but it reached a high of $5.79 in the same session. During the last five days, there has been a drop of approximately -4.94%. Over the course of the year, Aldeyra Therapeutics Inc shares have dropped approximately -0.92%. Shares of the company reached a 52-week high of $7.20 on 03/12/25 and a 52-week low of $1.14 on 04/03/25.
Support And Resistance Levels for Aldeyra Therapeutics Inc (ALDX)
According to the 24-hour chart, there is a support level at 5.26, which, if violated, would cause prices to drop to 5.12. In the upper region, resistance lies at 5.66. The next price resistance is at 5.92. RSI (Relative Strength Index) is 50.32 on the 14-day chart, showing neutral technical sentiment.
Is Aldeyra Therapeutics Inc subject to short interest?
Stocks of Aldeyra Therapeutics Inc saw a sharp steep in short interest on 2025-09-30 dropping by -0.2 million shares to 5.09 million. Data from Yahoo Finance shows that the short interest on 2025-08-29 was 5.29 million shares. A decline of -3.95% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 6.37 of the overall float, the days-to-cover ratio (short ratio) decline to 6.37.
Which companies own the most shares of Aldeyra Therapeutics Inc (ALDX)?
In terms of Aldeyra Therapeutics Inc share price expectations, FactSet research, analysts set an average price target of 7 in the next 12 months, up nearly 23.67% from the previous closing price of $5.66. Analysts anticipate Aldeyra Therapeutics Inc stock to reach 7 by 2025, with the lowest price target being 7. In spite of this, 2 analysts ranked Aldeyra Therapeutics Inc stock as Buy at the end of 2025. On December 16, 2020, Berenberg assigned a price target of “a Buy” to the stock and initiated coverage with a $32.
